Filing Details
- Accession Number:
- 0000899243-22-030475
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-06 19:00:22
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-06 19:00:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1629137 | Global Blood Therapeutics Inc. | GBT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1405253 | S Jeffrey Farrow | C/O Global Blood Therapeutics, Inc. 181 Oyster Point Blvd. South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-01 | 2,763 | $0.00 | 34,204 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-09-01 | 2,208 | $0.00 | 36,412 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-01 | 1,885 | $68.15 | 34,527 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-09-01 | 31,441 | $68.00 | 3,086 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2022-09-01 | 2,763 | $0.00 | 2,763 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2022-09-01 | 2,208 | $0.00 | 2,208 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,814 | No | 4 | M | Direct | ||
| 15,460 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 4,971 shares of Common Stock underlying the Reporting Person's RSUs.
- The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Billionaire Hedge Funds
